SCHEMBL6670710

SCHEMBL6670710

CCNC(=O)O[Si](C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.41
CHRNB2 P17787 1/20 0.37
CHRNB4 P30926 1/20 0.37
CHRNA3 P32297 1/20 0.37
CHRNA4 P43681 1/20 0.37
ALDH1A1 P00352 4/20 0.36
MMP1 P03956 1/20 0.36
MMP2 P08253 1/20 0.36
MMP3 P08254 1/20 0.36
MMP9 P14780 1/20 0.36
MMP8 P22894 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
KMT2A Q03164 4/20 0.34
MEN1 O00255 2/20 0.34
GAA P10253 2/20 0.33
HTT P42858 1/20 0.33
MCL1 Q07820 1/20 0.33
KDM4E B2RXH2 1/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL28340796 0.93 KMT2A (0.38) EPHX1CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL25447810 0.76 KDM4E (0.52) EPHX1KDM4E
SCHEMBL25166810 0.74 EPHX1 (0.66) EPHX1FAAH
SCHEMBL6647074 0.74 EPHX1 (0.43) EPHX1CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL7554569 0.73 MMP1 (0.31) MMP1MMP2MMP3MMP9MMP8
SCHEMBL25166940 0.73 SMN1; SMN2 (0.42) ALDH1A1SMN1; SMN2KMT2AHTTMAPT
SCHEMBL249164 0.73
Hydrochloric Acid SCHEMBL6646763 0.72 EPHX1 (0.42) EPHX1CHRNB2CHRNB4CHRNA3CHRNA4
Hydrochloric Acid SCHEMBL6649073 0.72 EPHX1 (0.42) EPHX1CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL25166821 0.72 ANPEP (0.41) CHRNB2CHRNB4CHRNA3CHRNA4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0017170-B1 IMPROVED PROCESS FOR THE PREPARATION OF CEPHAMYCIN ANTIBIOTICS MERCK & CO. INC. (US) 1983-04-13 EP claimed
EP-0017170-A1 Improved process for the preparation of cephamycin antibiotics MERCK & CO. INC. (US) 1980-10-15 EP claimed
US-4218563-A TRANSACYLATION IN PRESENCE OF N-TRIMETHYLSILYL LOWER ALKYL CARBAMATES MERCK & CO., INC. (US) 1980-08-19 US claimed
US-9249148-B2 Tris(hetero)arylpyrazoles and use thereof AICURIS GMBH & CO. KG (DE) 2016-02-02 US disclosed
WO-2015195179-A2 METAL ORGANIC FRAMEWORKS COMPRISING A PLURALITY OF SBUS WITH DIFFERENT METAL IONS AND/OR A PLURALITY OF ORGANIC LINKING LIGANDS WITH DIFFERENT FUNCTIONAL GROUPS. THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2015-12-23 WO disclosed
WO-2015161037-A1 VERY LOW DENSITY METAL ORGANIC FRAMEWORKS WITH LARGE PORE VOLUMES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2015-10-22 WO disclosed
WO-2015157239-A1 FUNCTIONALIZED AND MULTIVARIATE BTB-BASED METAL ORGANIC FRAMEWORKS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2015-10-15 WO disclosed
WO-2015121413-A1 NEW ACTIVE PHARMACEUTICAL INGREDIENT COMBINATIONS WITH COMPOUNDS BASED ON TRI(HETERO)ARYL PYRAZOLES AICURIS GMBH & CO. KG (DE) 2015-08-20 WO disclosed
US-20150203500-A1 TRIS(HETERO)ARYLPYRAZOLES AND USE THEREOF AICURIS GMBH & CO. KG (DE) 2015-07-23 US disclosed
EP-1266903-B1 Method of preparing an organosilicon compound DOW CORNING ASIA LTD (JP) 2004-09-29 EP disclosed
US-6750344-B1 MONOCYCLIC AMINE SCAFFOLD BEARING AT LEAST TWO SITES OF DIVERSITY, CYCLIZED TO FORM BICYCLIC AMINE SCAFFOLDS; 7-AMINO-PYRROLO(1,2-A)PYRAZIN-4-ONE COMPOUNDS ISIS PHARMACEUTICALS, INC. 2004-06-15 US disclosed
EP-1266903-A1 Method of preparing an organosilicon compound DOW CORNING ASIA, Ltd. (JP) 2002-12-18 EP disclosed
US-6326506-B1 HYDROSILATION DOW CORNING ASIA, LTD. (JP) 2001-12-04 US disclosed
US-6316626-B1 Amine compounds and combinatorial libraries comprising same ISIS PHARMACEUTICALS, INC. 2001-11-13 US disclosed
WO-1999012034-A1 AMINE COMPOUNDS AND COMBINATORIAL LIBRARIES COMPRISING SAME ISIS PHARMACEUTICALS, INC. (US) 1999-03-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150203500-A1 TRIS(HETERO)ARYLPYRAZOLES AND USE THEREOF TPMT, AHR, PAICS EPHX1 2158/4885CHRNB2 3866/4885CHRNB4 4074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.